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Abstract
Background: Despite an extensive literature on treatment interventions for patients with knee osteoarthritis, studies
comparing the efficacy of different exercise interventions and living the life as usual on quality of life, cartilage
quality and cost-effectiveness are lacking. The aim of the present study is to compare the efficacy of two different
exercise programs compared to a control group in individuals with established radiographic and symptomatic knee
osteoarthritis on self-reported knee-related quality of life, knee pain, physical function, and cartilage quality.
Methods/Design: A three-armed randomized controlled trial involving two exercise interventions and a control group
of individuals doing as they usually do is described. The patients will have mild to moderate radiographic osteoarthritis
according to the Kellgren and Lawrence classification (grade 2–3), and fulfill the American College of Rheumatology
clinical criteria, be aged between 45 and 65 years, and have no other serious physical or mental illnesses. The patients
will be randomly allocated to a strength exercise group; a cycling group, or a control group. The primary outcome is
the Knee injury and Osteoarthritis Outcome Score knee-related quality of life subscale. Secondary outcomes include all
five Knee Injury and Osteoarthritis Outcome Score subscales, morphological evaluation of cartilage including focal
thickness, subchondral bone marrow edema, proteoglycan content and collagen degradation (measured using
magnetic resonance imaging clinical sequences, T2 mapping and T1ρ), specific serum biomarkers, isokinetic muscle
strength, maximal oxygen uptake, quality of life (EuroQol 5D), and self-efficacy (Arthritis Self-Efficacy Scale). A sample
size calculation on the primary outcome showed that 207 individuals, 69 in each group, is needed to detect a clinically
relevant difference of 10 points with 80% power and a significance level of 5%. Assessments will be conducted at
baseline, 14 weeks, 1 year and 2 years post-randomization. The interventions will be a 14 weeks exercise program.
Discussion: Although exercise therapy has been found to be effective in knee osteoarthritis, the knowledge of the
underlying mechanisms for why exercise works is lacking. This study will contribute with knowledge on the efficacy of
strength exercise versus cycling on patient-reported outcomes, cartilage quality and cost-effectiveness.
Trial registration: Clinicaltrial.gov Identifier: NCT01682980.
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Background
Recent recommendations for treatment of knee osteo-
arthritis suggest exercise and physical activity in combin-
ation with patient education as first line treatments to
reduce pain and improve function [1-6]. During the last
decades, several randomized controlled trials (RCTs)
summarized in systematic reviews and meta-analyses
show that exercise and physical activity are important
interventions in a rehabilitation phase as well as in daily
life in reducing pain and improving function [7,8]. New
evidence support that exercise in almost any types works;
aquatic exercises [9] or land-based exercises [10], aerobic
exercises [11] or strength exercises [12-14], high-intensity
strength exercise or low intensity exercises [15,16]. Never-
theless, the effect sizes are low to moderate. Studies have
shown similar effect sizes for exercise therapy and pain re-
living drugs for patients with knee osteoarthritis, but exer-
cise therapy have fewer side-effects than may be seen for
drug therapy [3].
Despite of a huge amount of literature in this field,
we need more high-quality RCTs that give new know-
ledge with respect to the efficacy of different types of
exercise and the optimal exercise intensity and fre-
quency [2,6,8,17,18]. Adherence to exercise is another
important aspect associated to the efficacy of exercise
in patients with knee osteoarthritis. Wang et al. [12]
showed a possible association between high adherence
to exercise and improved pain and function. We
currently know too little about the dose–response rela-
tionship in exercise interventions on patients with osteo-
arthritis [12]. All existing literature concerning effective
treatment methods for osteoarthritis inquire clearer guide-
lines on exercise frequency, duration, and intensity. Fur-
thermore, studies identifying those patients responding
well to exercise (responders) and those who do not (non-
responders), are lacking. In addition, there is little know-
ledge on which subgroups benefit more (or less) from
exercise interventions. For instance, age, obesity, radio-
graphic severity, previously knee injury, and level of
physical activity are factors that we need more specific
knowledge about [19].
RCTs evaluating the efficacy of strength training ver-
sus aerobic exercise on knee-related quality of life
(QOL), pain and physical function in patients with mild
to moderate knee osteoarthritis are lacking [6,17].
Strength deficits may be caused by several aspects of
muscle function such as atrophy, pain inhibition, or acti-
vation failure [20]. Thus, both neuromuscular exercises
and strength exercises should be included in a strength
program to increase muscle function [20,21]. Few stud-
ies have evaluated the effect of neuromuscular exercises
targeting hip control in combination with progressive
strength exercises in patients with knee osteoarthritis
[22]. Different types of exercises such as strength training
including neuromuscular exercises versus aerobic exercise
might induce different adaptations in patients with knee
osteoarthritis. Hence, an investigation on how various
training methods might influence knee-related QOL, pain,
and physical function is necessary. To ensure a reliable
evaluation of the efficacy of an intervention, a control
group that is not receiving a particular intervention should
be included in RCTs.
Sparse evidence exists with respect to the efficacy of
different exercise interventions on structural progression
of the disease [23]. Significant biomarkers of structural
and compositional changes to bone, cartilage, and sy-
novium may be identified using magnetic resonance im-
aging (MRI). With the understanding that structural
changes in the knee joint starts early and that the osteo-
arthritis disease process affects several joint structures,
MRI has now been recommended to assess cartilage and
other knee joint pathologies in clinical trials. Quantita-
tive MRI techniques can capture tissue morphology and
biochemical composition [24]. Monitoring changes in
collagen integrity and proteoglycan content may give us
valuable insight into the understanding of mechanisms
explaining why exercise therapy reduces knee pain.
Osteoarthritis seems to be both a mechanically and an
inflammatory driven disease [25]. Thus, biomarkers from
proteins in serum and synovium have recently been used
to study changes in the knee osteoarthritis disease process.
Furthermore, some recent studies have reported the ef-
fect of exercise interventions on circulating cartilage
markers [26,27]. Exercises have shown to cause rise in
circulating cartilage markers like cartilage oligomeric
matrix protein (COMP), aggrecan and C-terminal telo-
peptides of collagen type II (CTX-II) [27,28]. Addition-
ally, exercises have shown to increase the production of
the anti-inflammatory mediator interleukin-10 [29].
The economic burden of knee osteoarthritis is growing
with respect to surgical interventions, non-pharmacological
and pharmacological treatments, and consequently social
indirect costs. However, according to a systematic review
by Pinto et al. [30] there is limited evidence for the cost-
effectiveness of non-surgical treatments for the manage-
ment of knee osteoarthritis. Thus, cost-effectiveness ana-
lyses comparing conservative treatment with usual care
are needed.
Aims
In patients with mild to moderate knee osteoarthritis,
the purpose of this study is to evaluate the efficacy of a
strength exercise program versus an aerobic exercise
program compared to a control group doing as they
usually do using knee-related QOL, physical function
and structural progression of the disease (cartilage qua-
lity). Furthermore, we aim to do cost-effectiveness ana-
lyses on exercise interventions compared to control
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group. One group will have tailored strength exercises, a
second group will perform cycling, and a third control
group will do as they usually do (but are asked to not
start physiotherapy treatment or exercises the first
4 month of the study period). The primary outcome will
be knee-related QOL at the 1 year follow-up. Secondary
outcomes include pain, other symptoms, function in ac-
tivities of daily living (ADL) and sport and recreation,
thigh muscle strength, aerobic capacity, cartilage morph-
ology, and biochemical composition as well as conven-
tional radiographic evaluation of the knee joints. In
addition, an explorative analysis of prognostic factors
for the main outcome after 2 years will be carried out.
The intervention will start with a 2 week preparation
phase followed by 12 weeks intervention phase. As-
sessments will be performed before the intervention
starts (baseline), after 14 weeks, 1 year, and 2 years
post-randomization. The study is a superiority trial
with the following hypotheses:
1. Clinical outcomes
In patients with mild to moderate knee
osteoarthritis:
 Strength exercise and cycling are both more
effective than doing as usual in improving knee-
related QOL during a 1 year follow-up.
 Strength training and cycling are both more
effective than doing as usual in improving knee
function during a 1 year follow-up.
 Strength training and cycling are both more
effective than doing as usual in postponing joint
replacement at 2 and 5 years post-randomization.
 Strength exercise is more effective than cycling in
improving knee function.
2. Structural outcomes
In patients with mild to moderate knee
osteoarthritis:
 Both strength exercise and cycling interventions
will have superior effects on cartilage
morphology, biochemical composition, and
radiographic joint space compared to the control
group.
 Cycling intervention is superior to strength
exercise in preserving cartilage morphology and
biochemical composition.
3. Cost-effectiveness
 Strength exercise and cycling are both more cost-
effective than doing as usual in patients with mild
to moderate knee osteoarthritis.
 A change in the Knee injury and Osteoarthritis
Outcome Score (KOOS) subscales of 8–10
points are clinically important differences in
patients with mild to moderate knee
osteoarthritis.
4. Subgroup analysis
 Those who respond well to the exercise programs
on KOOS pain have higher quadriceps strength
and maximal oxygen consumption at baseline
(reflecting higher physical activity level) than
those who do not respond to strength training
and cycling.
 Patients with mild radiographic osteoarthritis at
baseline will respond significantly better to the
interventions compared to those with moderate
radiographic osteoarthritis at baseline on KOOS
pain and QOL during the 2 year follow-up.
 Patients classified as “non-progressors” of
structural changes will respond significantly
better to the exercise intervention compared to
those who are defined as “progressors” over a
period of 2 years (progressors defined as Prasad
et al. [31]).
Methods/Design
This study presents a RCT adhering to the SPIRIT 2013
statement [32] including three groups: two intervention
groups (strength exercises and cycling) and one control
group (doing as usual, but those in the control group are
told to not start physiotherapy treatment during the first
4 months of the study period). Outcome assessments
will be performed at baseline, after the intervention
(14 weeks), 1 year after baseline, and 2 years after base-
line. In addition, those who refuse to take part in the
RCT will be asked to participate in an inception cohort
including baseline assessments and a 2 year follow-up.
Data from these patients will be used together with the
data from the RCT in the analyses of prognostic factors
for severe knee osteoarthritis.
Recruitment
The subjects will be included from the primary health
care in Oslo, and at university hospitals in Oslo and
Akershus (Figure 1). A part of the study participants will
be included from the Musculoskeletal Pain in Ullensaker
Study (MUST Part III) [33]. There will be one screening
of patients already participating in the MUST and one
screening of patients from the waiting lists at the univer-
sity hospitals and other hospitals in the Oslo area.
MUST Part I is a population based postal survey that
is sent to all inhabitants between 40 and 79 years old in
Ullensaker Municipality (n = 12 000). Those who self-
report osteoarthritis in their hands, knees or hips, are
invited to a clinical examination (MUST Part II) at
Diakonhjemmet hospital (estimated n = 600). Among
these, persons with knee osteoarthritis in line with the
inclusion and exclusion criteria will be recruited to this
RCT (MUST Part III) [33].
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Inclusion criteria
 Women and men aged 45–65 years
 Clinical knee osteoarthritis according to the American
College of Rheumatology Clinical Criteria [34]
 Kellgren and Lawrence (KL) radiographic
osteoarthritis grade 2 and 3 (mild to moderate
radiographic osteoarthritis)
Exclusion criteria
 Severe knee osteoarthritis according to the KL
classification (grade 4)
 Other known major musculoskeletal impairments in
the lower extremities or the back or prostheses in
any joint of the lower extremities
 Known serious coronary heart diseases or cancer
 Body mass index >35
 Scheduled for surgery in any joint
 Known mental or psychological diseases
 Known drug abuse
 Persons who already perform sports related
moderate physical activity more than two times a
week
 Contraindications for MRI
 Not speaking Norwegian language
Randomization and blinding
The participants who agree to participate in the RCT will
be randomly allocated into one of three groups: the strength
exercise group; the cycling group, or the control group. A
computer-generated randomization schedule will be used
to generate the randomization lists using blocks of six. A re-
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Figure 1 The schedule of enrolment, interventions, and assessments.
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prepare the envelopes for the randomization procedure.
The envelopes will be opened by the patients after the base-
line test. The study will be single-blinded such that the as-
sessors will be blinded to group allocation.
Primary outcome
 KOOS knee-related QOL
Secondary outcomes
 KOOS pain, other symptoms, activities of daily
living (ADL), and function in sport/recreation
 Health-related quality of life (EuroQOL-5D, EQ-5D)
 Radiographic knee osteoarthritis progression (joint
space and KL score)
 Isokinetic muscle strength
Exploratory outcomes
 Cartilage morphology measures (MRI–T2 mapping
and T1ρ)
 Serum proteins
 Maximal oxygen consumption (VO2max)
 Self-efficacy for pain (Arthritis Self-Efficacy Scale, ASES)
Assessments
Primary outcome
Knee-related QOL The KOOS [35] will be included to
measure knee-related QOL at baseline, after the interven-
tion, and after 1 year and 2 years post-randomization. The
KOOS is a self-administered knee-specific questionnaire
containing 5-item Likert scales on pain, other symptoms,
ADL, function in sports and recreation and knee-related
QOL. KOOS has been validated for subjects with post-
traumatic osteoarthritis [36] and includes The Western
Ontario and McMaster Universities Arthritis Index
(WOMAC), which is widely used to measure pain and phys-
ical function in patients with osteoarthritis [37]. Primary
outcome will be the subscale on knee-related QOL of life as
this subscale is sensitive for detecting impaired function for
patients with knee osteoarthritis [38]. All the KOOS sub-
scales will be included separately as secondary outcomes.
Secondary outcomes
Radiological examination Conventional radiographic
procedure will be performed at baseline and at the 2 year
follow-up. For the frontal plane images, the SynaFlexerW
frame for standardized positioning as described by
Kothari et al. [39] will be used. In this protocol, a 10°
caudal beam angulation ensures alignment of the beam
with the medial tibial plateau. A standardized degree of
knee flexion (20°) and external foot rotation (10°) are
achieved using the frame. X-rays will also be taken in a
lateral view and tangentially of the patella, bilaterally.
The KL classification system [40] will be used for grad-
ing the radiographs (Table 1).
Grade 2 will be modified according to suggestions by
Felson et al. [41] such that definite osteophytes will be reg-
istered as grade 2a and definite osteophytes and possible
joint space narrowing will be registered as 2b. In retro-
spect, all the radiographs will be reclassified blindly and
independently by an experienced radiologist, according to
the above defined criteria. Minimal joint space width
(JSW) will be measured and used to define progression.
Using a semi-flexed view and at least 2 years follow-up
time, JSW measurements have been shown to be sensitive
to change [42] and have shown good evidence for reliabil-
ity and responsiveness [43]. A standardized response mean
(SRM) of 0.71 (95% CI of 0.44-0.98) has been calculated
for conventional radiographic JSW in knee osteoarthritis
trials using semi-flexed views with a trial duration of more
than 2 years [42]. In order to evaluate structural progres-
sion using changes in JSW, a reliability study will be
performed to establish the smallest detectable difference
(SDD) within this study for the JSW measurements. This
is based on the OARSI-OMERACT recommendations for
structural progression using conventional radiographic
measurements. The SDD will be determined from Bland
and Altman plots, meaning a change in JSW beyond the
measurement error. Progression and cut-off for radio-
logical progression will be defined based on the measure-
ment error within this study.
Health related QOL Health-related QOL will be assessed
by the EQ-5D (EuroQoL Group 1990) [44].
The cost-effectiveness analysis will compare the po-
tential effect of the interventions by using the KOOS
QOL and the EQ5D as the measure of effectiveness.
Costs of the study treatment (direct costs) will be esti-
mated using a bottom-up approach. We will register the
number of exercise sessions, personnel involved and
their time spent, and materials and practice space used.
Costs to the healthcare system incurred due to knee
Table 1 Kellgren and Lawrence classification system [40]
Grade Description
0 No changes
1 Doubtful narrowing of joint space and possible osteophytic
lipping
2 Definite osteophytes and possible narrowing of joint space
3 Moderate multiple osteophytes, definite narrowing of joint
space, and some sclerosis, and possible deformity of bone ends
4 Large osteophytes, marked narrowing of joint space, severe
sclerosis and definite deformity of bone ends
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osteoarthritis (indirect costs) will be recorded by a cost
diary, including registrations of number of visits to a
general practitioner, physical or manual therapist, med-
ical specialist, social worker, and alternative therapist,
number of days of hospitalization and/or rehabilitation,
use of medication (both on prescription and over the
counter medication), and number of days of sick leave
from work. The costs of work absenteeism will be esti-
mated by the number of days absent from work multi-
plied by the average wage rate. The cost diary will be
recorded at baseline and after 3, 6, 9, and 12 months
post-randomization by calling the included study partic-
ipants at 6 and 9 months.
Muscle strength tests Isokinetic equipment (Biodex
2000) will be used to evaluate the mm. quadriceps and
hamstrings muscle performance. Isokinetic muscle test-
ing is commonly used in the literature and has been vali-
dated for measurement of muscle strength performance
and the reliability has been reported to be adequate [45].
A procedure involving concentric knee extension and
knee flexion in a range of 90 degrees with 5 repetitions
at 60°/sec will be performed.
Explanatory outcomes
MR imaging and collection of blood samples will com-
mence when 36 individuals have been included in each
group (i.e. performed on the last 33 individuals of each
group) due to the high costs involved. MR images will
be obtained bilaterally (i.e. both knees) and blood sam-
ples will be drawn at baseline, post-intervention, and at
1 and 2 years post-randomization.
Magnetic resonance imaging MRI examinations will be
conducted using a 3.0 Tesla Philips INGENIA scanner
(Release 4.1.2.1, from August 2012) with 8-channel
knee-coil at the Department of Radiology at Oslo Uni-
versity Hospital. MRI has shown to have inherent
strength and advantages to visualize tissue pathology
and has shown good reliability and responsiveness [46].
A separate MRI method protocol will be developed to as-
sess the utility, limitations, validity and reliability of T2
mapping and T1ρ sequence methods in evaluating the
quality of cartilage in patients with mild knee osteoarth-
ritis. The MRI evaluation will include morphological
evaluation of cartilage, detecting focal thickness reduction
or defects. Focal areas of subchondral bone marrow
edema will be noted. Assessment of cartilage quality (pro-
teoglycan content and collagen degradation) will be made
using two sequences: T2 mapping and T1ρ. T2 mapping
have been shown to correlate with collagen degeneration
in patients with knee osteoarthritis [47] whereas T1ρ has
been shown to detect changes in the proteoglycan content
of the cartilage. Both were suggested as viable tools for
detecting early degeneration and progression of osteoarth-
ritis disease and both have shown biochemical changes in
the knee articular cartilage in the absence of radiographic
evidence of knee osteoarthritis [48].
Laboratory measures Molecular biomarkers of cartilage
turnover will be assessed in serum. Serum samples of
venous blood will be collected at the same visit as image
acquisition (3 vacutainer tubes, each containing 6 ml).
After being centrifuged at 1800 g for 10 minutes, samples
will be stored at −80 degrees Celsius in 1 mL aliquot
tubes. We will investigate the longitudinal change of
cartilage specific biomarkers (including, but not limited
to a specific fragment of Aggrecan (ARGS), Collagen −9
and Cartilage Oligomeric Matrix Protein (COMP) and
cytokines (including, but not limited to IL-6, TNF-α
and TGF-β).
Maximal oxygen consumption Maximal oxygen con-
sumption (VO2max) will be measured on an ergometer
cycle (Monark 839E, Sweden) at baseline, at post-
intervention, and at the 1 and the 2 year follow-ups. A car-
diovascular examination will be performed at the screen-
ing to exclude those with serious and unstable coronary
heart diseases. The test protocol includes a 20 minute pro-
gressive warm-up at 45–90% VO2max, followed by an all-
out incremental “ramp” test, lasting approximately 4–6 mi-
nutes. During the “ramp” test, the cadence will remain as
steady as possible at 90 repetitions per maximum, and the
workload will increase by 25 Watts every 30 second, to a
supramaximal workload and totally exhaustion (rate of
perceived exertion 17–19).
Self-efficacy for pain Several studies including patients
with osteoarthritis have found that a patient’s perceived
self-efficacy is related to health outcomes and the course
of disease progression [49,50]. ASES will be included as
a measure of the patients’ self-efficacy for pain. Perceived
self-efficacy is defined as a person’s judgment or belief of
their ability to change, manage or execute tasks related
to pain [50]. It is concerned not with the skill one has,
but measures a changeable psychological aspect of pain
[51]. A modified version of ASES contains 11 questions
regarding the patient’s certainty to perform various tasks
related to pain and symptoms, where each item is rated
from 1 (very uncertain) to 5 (very certain). Good concur-
rent validity and internal reliability has been reported for
the original version of the scale [51].
Other assessments Background variables such as height,
weight, physical activity, type of work or disability pen-
sions, range of motion, knee joint alignment measured
with an inclinometer [52], numeric change scale, analge-
sics consumption or other medications, previously knee
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injuries, and adverse events will be collected at the base-
line test, the post-intervention test and at 1 and 2 year
follow-ups. Cases of joint replacement will be recorded
at the 2 year follow-up.
Interventions
The interventions will be delivered by guided physio-
therapists at selected physical therapy institutes in the
Oslo and Akershus area. The strength exercise program
will be based on previously developed exercise programs
[14], focusing on heavy resistance training and neuro-
muscular training including one leg exercises and bal-
ance training. The program has been planned according
to American College of Sports Medicines (ACSMs)
guidelines for strength progression in healthy adults
[53]. The aerobic exercise will be performed to improve
physical function and cartilage quality and the dosage
has been planned according to general guidelines for
training parameters in people with pain associated to
osteoarthritis, as developed by the American Geriatrics
Society [2]. The intervention programs will last for
12 weeks with 2–3 training sessions per week. In addition,
the patients will go through a pre-phase of 2 weeks to pre-
pare for the intervention programs. The patients in all
three groups will be told to stick to the exercise program
or usual care for the 12 weeks of intervention to make
sure they do not increase or change usual activity level
parallel with the intervention. The included patients will
be followed closely to ensure that the exercises are
performed adequately and to ensure the progression of
intensity. A description of the interventions and the
response to the program depending on patient charac-
teristics will be performed in a separate study. The def-
inition of responders will be defined according to the
OMERACT-OARSI set of responder criteria, including
improvement in at least two of the following three
criteria: pain ≥ 20% and absolute change ≥ 10%, or phys-
ical function ≥ 20% and absolute change ≥ 10%, or pa-
tient’s global assessment ≥ 20% and absolute change ≥
10% [54]. A brief description of the three interventions
can be seen below:
Strength exercise intervention
The strength exercise program will be delivered 2–3 times
per week for 12 weeks, 8–10 repetitions maximum (RM)
in 3 series with approximately 30 seconds to 1 minute
pause between the series. One of the training sessions may
be performed at home. The patients will go through a
2 weeks phase before the strength program including
neuromuscular exercises and strength exercises on low
intensity. The patients will warm up 5–10 minutes on
an ergometer cycle or a treadmill according to the pa-
tients’ desire. The following muscle groups will be
trained: Quadriceps and hamstrings, hip abductors and
extensors, and calf muscles. A home exercise program
will be delivered including one leg exercises and balance
exercises. Progression will follow a 2+ principle [55].
For instance, when the study participant is able to
perform 2 more repetitions in a set of 3×8, more loads
are required.
Aerobic exercise intervention
In the present study, the main aim of the aerobic exer-
cise is to improve cartilage quality, in addition to the
general health effects physical activity gives. Both over-
loading and underloading may cause cartilage degrad-
ation, but moderate loading has been shown to be
beneficial for joint health because of mechanosensitive
chondroprotective pathways [23,56]. However, these
pathways need to be further elucidated to identify the
causation. Based on the moderate loading benefits, erg-
ometer cycling for 45 minutes 2–3 times a week, in-
cluding 10 minutes warm up, 30 minutes on moderate
loading (75% of max heart rate) and 5 minutes cool
down will be required. For instance, a patient with a max-
imal heart rate of 160 and rest heart rate of 60 will be re-
quired to cycle at a heart rate of about 135 using the
formula for heart rate reserve (160-rest heart rate of 60 ×
0.75 + rest heart rate of 60). The patients who will be allo-
cated to the cycling group will be told to measure their rest
heart rate before the intervention starts to ensure moder-
ate loading during the cycling sessions.
Compliance to the interventions
The patients will be asked to report all training sessions
in detailed training diaries distributed to the patients
after randomization, including type of exercise, loading,
and progression. Pain during training will be reported
using the visual analogue scale (0–10) (VAS). A cut off
value of 4–6 is suggested to be acceptable pain during or
after the exercise session in patients with knee osteo-
arthritis [57]. The diaries will be controlled weekly by
the physiotherapist to ensure compliance with the pro-
gram. An optimal goal is that the subjects should
complete minimum 80% of the planned exercise sessions
according to ACSMs guidelines.
Control group
A control group doing as usual will be included to con-
trol for the natural course of knee osteoarthritis. They
will be told to not start a new physiotherapy treatment
period the first 4 months after inclusion in the study.
The group will be tested at baseline, after 14 weeks,
after 1 year and 2 years with the same tests as for the
intervention groups. Those who are in the control
group will get exercise advice according to our interven-
tion programs after they have finished the first 4 months
of the study if they are interested.
Øiestad et al. BMC Musculoskeletal Disorders 2013, 14:266 Page 7 of 10
http://www.biomedcentral.com/1471-2474/14/266
Sample size calculation
Primary outcome for the RCT will be the KOOS
subscale knee-related QOL (0–100 scale). A clinical im-
portant difference in the KOOS subscales has been sug-
gested to be 8–10 points [58]. Based on 10 points
expected difference between the intervention groups and
the control group and a standard deviation of 20 on
QOL, 63 patients are needed in each group with signifi-
cance level of 0.05, and power of 80% using Popocks
formula: n = 2σ2/(μ1- μ2)
2 * f(α,β). With an estimated
drop-out rate of 10% a total number of 207 subjects will
be randomized either into the strength exercise group
(n = 69); the cycling group (n = 69), or the control group
(n = 69).
Statistical methods
The analyses will be performed using intention-to-
treat mixed linear models and Student t-tests. For
mixed models, the baseline score will be included as a
covariate, the subjects as random effect and the treat-
ment condition as fixed factor. We will consider using
the closest match missing data imputation for repeated
measures data [59]. The cost-effectiveness analysis will
be conducted from the societal perspective and ac-
cording to the intention-to-treat principle. An incre-
mental cost-effectiveness ratio will be calculated by
dividing the between-group difference in costs by the
between-group difference in effects. Cost-effectiveness
ratios will be estimated using bootstrapping techniques
and graphically presented on cost-effectiveness planes.
Acceptability curves and net monetary benefit will also
be estimated. Sensitivity analysis on the most import-
ant cost drivers will be performed in order to assess
the robustness of the results. The statistical analyses
will be discussed and co-worked with our statisticians
at the Oslo University Hospital and the Norwegian
School of Sport Sciences, respectively, and with our
international collaboration groups.
Ethical perspectives and project funding
The study is approved by the Regional Ethical Commit-
tee and The Data Inspectorate in Norway (Ref. 2012/
334). All the included subjects will sign an informed
written consent, and will be able to withdraw from
participation in the study at any time point. The Re-
search Council of Norway is funding the first part of
the project including the 1 year follow-up in a three
years full time post doc position (Ref. H10/213335).
Furthermore, the study will be collaborated between
researchers from the Oslo University Hospital (Depart-
ment of Orthopeadics and Department of Radiology),
Diakonhjemmet Hospital, Oslo University College,
Akershus University Hospital (Department of Ortho-
paedics) and Lund University.
Discussion
Guidelines and meta-analyses request more RCTs evalu-
ating type, intensity, and frequency of exercise which
may contribute in the knowledge of dose–response rela-
tionship. Furthermore, we do not know underlying
mechanisms for why exercise work analyzing data from
imaging or blood samples. We have presented the ra-
tionale and design of a RCT for investigating the efficacy
of different types of exercise interventions on patient-
reported clinical outcomes as well as cartilage quality
and cost-effectiveness in patients with mild to moderate
knee osteoarthritis. We argue that this study will con-
tribute with important knowledge that is requested. If
the study succeeds in demonstrating a significant posi-
tive effect on clinical, radiological, and cost-effectiveness
outcomes, the potential gain is large because of the in-
creasing number of patients suffering from knee osteo-
arthritis in the society.
Conclusion
This study protocol presents a RCT on the efficacy of
different types of exercise interventions on patient-
reported clinical outcomes as well as cartilage quality
and cost-effectiveness in patients with mild to moder-
ate knee osteoarthritis. The RCT will contribute with
knowledge on the efficacy of strength exercise versus
cycling on patient-reported outcomes, cartilage quality
and cost-effectiveness.
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